Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000008

President and CEO sold 45,397 shares at $120.03 ($5,449,002)

  • President and CEO acquired 45,397 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kramer Robert President and CEO 2021-02-08 Option exercise +32,397 $30.86 $999,771 171,607 D: show line 1 in the form
Kramer Robert President and CEO 2021-02-08 Sale −32,397 $120.03 $3,888,612 139,210 D: show line 2 in the form
Kramer Robert President and CEO 2021-02-08 Option exercise +13,000 $30.63 $398,190 152,210 D: show line 3 in the form
Kramer Robert President and CEO 2021-02-08 Sale −13,000 $120.03 $1,560,390 139,210 D: show line 4 in the form
Open-market sales · 45,397 sh · avg $120.03 · $5,449,002

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kramer Robert President and CEO 2021-02-08 Option exercise · Employee Stock Options (Right to Buy) −32,397 $120.03 $3,888,612 0 D: show line 5 in the form
Kramer Robert President and CEO 2021-02-08 Option exercise · Employee Stock Options (Right to Buy) −13,000 $120.03 $1,560,390 19,638 D: show line 6 in the form
Loading xslF345X03/wf-form4_161290942063298.xml…